<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:NCBITaxon="http://purl.obolibrary.org/obo/NCBITaxon#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                            NIH Public Access <br />                             Author Manuscript <br />                             J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                            Published final edited form as: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             J Neurochem. 2010 March ; 112(6): 1593&#8211;1604. doi:10.1111/j.1471-4159.2010.06568.x. <br />  <br />  <br />  <br />                            MKK6 binds regulates expression Parkinson&#8217;s disease- <br />                            related protein LRRK2 <br />  <br />                            Cindy H. Hsu1, Diane Chan1, Elisa Greggio2, Shamol Saha1, Maria D. Guillily1, Andrew <br />                            Ferree1, Kesav Raghavan1, Grace C. Shen1, Lilach Segal1, Hoon Ryu3, Mark R. Cookson2, <br />                            Benjamin Wolozin1,* <br />                            1Department Pharmacology, Boston University School Medicine, Boston, MA 02118-2526 <br />  <br />                            2Laboratory    Neurogenetics, National Institute Aging, Bethesda, MD 20892 <br />                            3Department      Neurology, Boston University School Medicine, Boston, MA 02118-2526 <br />  <br />                            Abstract <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 Mutations leucine-rich repeat kinase 2 (LRRK2) prevalent causes late-onset Parkinson&#8217;s <br />                                 disease (PD). Here, LRRK2 binds mitogen-activated protein kinase (MAPK) <br />                                 kinases MKK3, 6, 7, LRRK2 able phosphorylate MKK3, 6 7. Over- <br />                                 expression LRRK2 MKK6 increased steady state levels protein that <br />                                 observed over-expression protein alone. Co-expression increased levels MKK6 in <br />                                 membrane cytoplasm. The increased expression LRRK2 MKK6 <br />                                 requires MKK6 activity. The disease-linked LRRK2 mutations, G2019S, R1441C I2020T, <br />                                 enhance binding LRRK2 MKK6. <span id='am-40' about='obo:NCBITaxon_169495' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_169440 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_7147 obo:NCBITaxon_43733 obo:NCBITaxon_33154 obo:NCBITaxon_43738 obo:NCBITaxon_480117 obo:NCBITaxon_33317 obo:NCBITaxon_169449 obo:NCBITaxon_480118 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_43750 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_7203 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_169455 obo:NCBITaxon_50557 obo:NCBITaxon_43741'><span id='am-41' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-43'  ></span><span id='am-44' property="rdfs:label" content="This" datatype="xsd:string"></span>This</span> interaction supported vivo studies in <br />                                 C. elegans. RNAi knockdown C. elegans endogenous orthologs MKK6 p38, sek-1 <br />                                 pmk-1, abolishes LRRK2-mediated protection mitochondrial stress. These results <br />                                 confirmed deletion sek-1 C. elegans. These <span id='am-86' about='obo:NCBITaxon_1369087' typeof='obo:NCBITaxon_37567 owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_37570 obo:NCBITaxon_41191 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_41196 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_95182 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7100 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-87' property="rdfs:label" content="Data" datatype="xsd:string"></span><span id='am-88' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-89'  ></span><span id='am-90' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>data</span> demonstrate MKKs and <br />                                 LRRK2 function similar biological pathways, support role LRRK2 modulating the <br />                                 cellular stress response. <br />  <br />  <br />                            Keywords <br />                                 MAP kinase; phosphorylation; C. elegans; JNK; p38; membrane <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                            INTRODUCTION <br />                                             Parkinson&#8217;s disease (PD) common neurodegenerative movement disorder <br />                                             (Olanow et al. 2009). Although majority PD cases sporadic, identification of <br />                                             genes responsible familial parkinsonism enhanced understanding the <br />                                             pathogenesis PD. Autosomal-dominant mutations leucine-rich repeat kinase 2 <br />                                             (LRRK2) particularly interesting associated sporadic PD a <br />                                             familial form PD resembles sporadic PD (Zimprich et al. 2004). The majority of <br />                                             LRRK2 cases exhibit pathological findings consisting &#945;-synuclein inclusions, is <br />                                             pathological hallmark PD (Zimprich et al. 2004). However, cases LRRK2 <br />                                             mutations exhibit pleiomorphic pathology, including tau inclusions, inclusions <br />                                             (Zimprich et al. 2004). <br />  <br />  <br />  <br />                            *Correspondence to: Benjamin Wolozin, M.D., Ph.D., Department Pharmacology, Boston University School Medicine, 715 <br />                            Albany St, R-614, Boston, MA 02118-2526, 617-414-2652 (Phone), 617-414-2651 (Fax), bwolozin@bu.edu. <br />                             Hsu et al.                                                                                              Page 2 <br />  <br />  <br />                                            The LRRK2 protein conserved domains including: leucine-rich domain (LRR), <br />                                            Roc GTPase domain, COR (carboxy-terminal Ras) domain, kinase domain, a <br />                                            WD40 domain carboxy-terminal (Zimprich et al. 2004, Greggio &amp; Cookson 2009). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            The G2019S familial mutation leads increased LRRK2 autophosphorylation kinase <br />                                            activity (West et al. 2005, Smith et al. 2005, Smith et al. 2006, Greggio et al. 2006). Other <br />                                            mutations appear affect kinase activity lesser extent (West et al. 2005, Smith et al. <br />                                            2005, Smith et al. 2006, Gloeckner et al. 2009, Jaleel et al. 2007). The over-expression of <br />                                            mutants lead increased caspase-dependent toxicity primary neurons <br />                                            (Macleod et al. 2006, Iaccarino et al. 2007, Ho et al. 2009). Missense mutations causing <br />                                            disruption LRRK2 GTPase activity shown lead cell death (Ito et al. <br />                                            2007, Lewis et al. 2007, Li et al. 2007). In addition, LRRK2 appears regulate neurite <br />                                            morphology rodents, human neuronal cell lines (Macleod et al. 2006, Plowey et al. <br />                                            2008). However, exact mechanism LRRK2 lead pathogenesis PD <br />                                            remains critical unanswered question. <br />  <br />                                            The kinase domain LRRK2 shares homology receptor interacting protein kinases <br />                                            (RIPs) mixed lineage kinases (MLKs) (Greggio &amp; Cookson 2009). RIP kinases, as <br />                                            RIP-1, mediate signaling death receptors, activate stress kinases (JNK p38) <br />                                            NF-kB (Festjens et al. 2007). The RIP kinase <span id='am-17' about='obo:NCBITaxon_family' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-18' property="rdfs:label" content="family" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>family</span> particularly interesting in <br />                                            light recent observations LRRK2 mediates signaling death receptor <br />                                            protein Fas binding protein (Ho et al. 2009). MLKs family serine/threonine protein <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            kinases function upstream MAPK signaling cascades (Silva et al. 2005). The <br />                                            MLK family kinases activate c-jun amino-terminal kinase (JNK) pathway by <br />                                            phosphorylating MAPK kinase 4 7 (MKK4 MKK7), p38 pathway by <br />                                            phosphorylating MAPK kinase 3 6 (MKK3 MKK6). These MKKs then <br />                                            recruited multi-protein complex scaffold proteins JNK Interacting Proteins (JIPs) <br />                                            1&#8211;3 (Gallo &amp; Johnson 2002). The homology LRRK2, RIPs MLKs lead to <br />                                            hypothesize LRRK2 interact MKKs manner similar kinases. <br />  <br />                                            Our data demonstrate interactions LRRK2 MKK 3, 6, 7. We observed that <br />                                            LRRK2 binds MKKs COR kinase domains, phosphorylates the <br />                                            MKKs. The G2019S, R1441C I2020T LRRK2 mutations increase association of <br />                                            LRRK2 MKK6. Binding LRRK2 MKK6 associated increased levels of <br />                                            proteins plasma membrane cytoplasm, change dependent the <br />                                            activity MKK6. LRRK2 able phosphorylate MKK6. We validated importance of <br />                                            MKK6 LRRK2 function mitochondrial stress using RNAi knockdown or <br />                                            deletion transgenic LRRK2 C. elegans. Our data suggest intriguing mechanism by <br />                                            MKK6 regulate function LRRK2, suggests role LRRK2 the <br />                                            stress response. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               MATERIALS AND METHODS <br />                               Constructs <br />                                            Wild-type (WT) mutant LRRK2 V5-His tagged constructs generated described <br />                                            Greggio et al. (Greggio et al. 2006). All pathogenic, kinase dead, deletion LRRK2 <br />                                            constructs utilized study illustrated schematically Fig. S1. pRSV-Flag-MKK3, <br />                                            dominant negative pRSV-Flag-MKK3 (<span id='am-70' about='obo:NCBITaxon_1416571' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_116706 obo:NCBITaxon_6804 obo:NCBITaxon_131567 obo:NCBITaxon_116704 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_33154 obo:NCBITaxon_72041 obo:NCBITaxon_6681 obo:NCBITaxon_6656 obo:NCBITaxon_6692 obo:NCBITaxon_6682 obo:NCBITaxon_6657 obo:NCBITaxon_1206794 obo:NCBITaxon_6683 obo:NCBITaxon_88770 obo:NCBITaxon_6752 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_553065 obo:NCBITaxon_6072'><span id='am-71'  ></span><span id='am-72' property="rdfs:label" content="Ala" datatype="xsd:string"></span><span id='am-73' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-74' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Ala</span>), pcDNA3-Flag-MKK6, dominant negative <br />                                            pcDNA3-Flag-MKK6 (K82A), pcDNA3-Flag-MKK7, dominant negative pcDNA3- <br />                                            Flag-MKK7 (K82A) generous gifts Dr. <span id='am-76' about='obo:NCBITaxon_1009818' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_263623 obo:NCBITaxon_41084 obo:NCBITaxon_33154 obo:NCBITaxon_71526 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_41088 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_7080 obo:NCBITaxon_50557 obo:NCBITaxon_115347 obo:NCBITaxon_7041'><span id='am-77' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-78'  ></span><span id='am-79' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-80' property="rdfs:label" content="Roger" datatype="xsd:string"></span>Roger</span> Davis (University of <br />                                            Massachusetts). Recombinant MKK3, 6 7 purchased R&amp;D Systems. <br />  <br />  <br />  <br />  <br />                                                 J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                                Page 3 <br />  <br />  <br />                               Cell culture <br />                                              HEK-293 HEK-293FT cells maintained DMEM (Invitrogen) supplemented with <br />                                              10% FBS (<span id='am-1' about='obo:NCBITaxon_649065' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33154 obo:NCBITaxon_1206795 obo:NCBITaxon_216294 obo:NCBITaxon_649145 obo:NCBITaxon_69555 obo:NCBITaxon_413196 obo:NCBITaxon_6447 obo:NCBITaxon_33317 obo:NCBITaxon_6448 obo:NCBITaxon_2759 obo:NCBITaxon_216293 obo:NCBITaxon_6072'><span id='am-2' property="rdfs:label" content="Atlanta" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-4'  ></span><span id='am-5' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Atlanta</span> Biologicals), 1&#215; non-essential amino acids, penicillin (100 units/ml), and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              streptomycin (100 &#181;g/ml). Transfections performed using FuGENE 6.0 reagent (Roche <br />                                              Applied Science) HEK-293 cells Lipofectamine 2000 (Invitrogen) HEK-293FT <br />                                              cells. <br />  <br />                               Quantitative real-time PCR assay <br />                                              HEK-293 cells transfected LRRK2 constructs RNA extracted 8 hours <br />                                              post-transfection using Qiagene RNeasy mini kit. Intact RNA checked running in <br />                                              1.0% agarose gel quantified spectrometrically (NanoDrop ND-1000) proceeding <br />                                              subsequent steps. 1 &#181;g total RNA reverse-transcribed using iScript cDNA <br />                                              synthesis kit (Bio-Rad) according manufacturer&#8217;s instructions. Real-time PCR was <br />                                              performed MyiQ&#8482; Detection System (Bio-Rad) using iQ SYBR Green supermix. <br />                                              Expression levels target gene calculated 2-&#916;&#916;CT method (Livak &amp; <br />                                              Schmittgen 2001). All analyses performed triplicates. Primers used c-jun were <br />                                              5&apos;-GGAACAGGTGGCACAGCTTAAACA-3&apos; (forward) 5&apos;- <br />                                              TTGCAACTGCTGCGTTAGCATGAG-3&apos; (reverse) GAPDH were <br />                                              5&apos;TGGCCAAGGTCATCCATGACAACT-3&apos; (forward) 5&apos;- <br />                                              CACAGTCTTCTGGGTGGCAGTGAT-3&apos; (reverse). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Co-immunoprecipitation <br />                                              HEK-293FT cells co-transfected V5-His tagged LRRK2 Flag-tagged MKK <br />                                              constructs, harvested immunoprecipitation (IP) buffer consisted 150 mM NaCl, 20 <br />                                              mM Hepes (pH = 7.4), 50 mM &#946;-glycerophosphate, 5 mM sodium fluoride, 1% Triton <br />                                              X-100, 10% glycerol, 2 mM EGTA, 1 mM sodium orthovanadate, 1&#215; protease inhibitor <br />                                              cocktail (Sigma) LRRK2-MKK3 co-immunoprecipitation 0.5% Triton-X, 1 mM <br />                                              EDTA 1X PBS 1X protease inhibitor cocktail (Sigma) co- <br />                                              immunoprecipitations. The lysates rotated 4 &#176;C 30 minutes followed by <br />                                              centrifugation 13,000g 10 minutes. The supernatant pre-cleared Protein G <br />                                              Sepharose 4 Fast Flow (Amersham) followed addition appropriate antibody and <br />                                              rotated overnight 4 &#176;C. Protein G Sepharose added pull antibody pre- <br />                                              complex. The Sepharose beads stringently washed times IP buffer once <br />                                              50 mM Tris (pH = 8) wash buffer. The immunoprecipitation proteins eluted in <br />                                              lithium dodecyl sulphate (LDS) sample buffer (Invitrogen) heating 95 &#176;C 3 <br />                                              minutes. Immunoprecipitates resolved 3&#8211;8% NuPAGE Tris-Acetate 4&#8211;20% Tris- <br />                                              <span id='am-6' about='obo:NCBITaxon_3846' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_3814 obo:NCBITaxon_1 obo:NCBITaxon_72025 obo:NCBITaxon_131567 obo:NCBITaxon_3803 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_163735 obo:NCBITaxon_91827 obo:NCBITaxon_131221 obo:NCBITaxon_71240 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_91835 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_71275 obo:NCBITaxon_3193'><span id='am-7' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-8' property="rdfs:label" content="Glycine" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-10'  ></span>Glycine</span> gels (Invitrogen) analyzed western blot. Antibodies purchased from <br />                                              Sigma (V5, Flag, c-Myc, actin), Calbiochem (Calnexin), Biodesign (GAPDH). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              For immunoaffinity chromatography, lysates (5 mg) generated using IP buffer, <br />                                              loaded column containing 400 &#181;l anti-V5-agarose (Sigma), washed IP buffer <br />                                              followed 50 mM Tris (pH 8) wash buffer, eluted V5-peptide (1 mg/ml, <br />                                              Sigma). Fractions analyzed immunoblot described above. <br />  <br />                               Subcellular fractionation <br />                                              HEK-293FT cells transfected appropriate constructs 48 hours, washed <br />                                              cold 1&#215; PBS, lysed relaxation buffer consisted 100 mM KCl, 3 mM NaCl, <br />                                              3.5 mM MgCl2, 1.25 mM EGTA, 10 mM PIPES, 1&#215; protease inhibitor cocktail. The <br />                                              lysates centrifuged 500g 5 minutes eliminate cellular debris, the <br />                                              supernatant centrifuged 100,000g 1 hour 4 &#176;C separate cytosolic <br />                                              fraction. The pellets solublized 200 &#181;l relaxation buffer obtain membrane <br />  <br />  <br />                                                   J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                             Page 4 <br />  <br />  <br />                                            fraction. Equal amounts lysate loaded resolved 3&#8211;8% NuPAGE Tris-Acetate <br />                                            4&#8211;20% Tris-Glycine gels western blotting. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Kinase assays <br />                                            Kinase assays performed described Gloeckner et al (Gloeckner et al. 2009, <br />                                            Greggio et al. 2007). Recombinant LRRK2 obtained Invitrogen. The MKKs were <br />                                            generated transfecting 293FT cells Flag-MKK constructs, immunopurifying the <br />                                            Flag-MKK anti-Flag M2 agarose eluting Flag peptide (25 &#181;g peptide/run, <br />                                            using 10 cm dish purification). 25 nM recombinant LRRK2 (Invitrogen) was <br />                                            incubated ~ 1&#181;M Flag-tagged MKK substrate protein 30 &#181;L assay buffer (25 mM <br />                                            Tris&#8211;HCl pH 7.5, 5 mM <span id='am-11' about='obo:NCBITaxon_3554' typeof='owl:Thing obo:NCBITaxon_78536 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_3398 obo:NCBITaxon_1437183 obo:NCBITaxon_33090 obo:NCBITaxon_3563 obo:NCBITaxon_91827 obo:NCBITaxon_71240 obo:NCBITaxon_131221 obo:NCBITaxon_58024 obo:NCBITaxon_1437201 obo:NCBITaxon_58023 obo:NCBITaxon_3524 obo:NCBITaxon_2759 obo:NCBITaxon_35493 obo:NCBITaxon_3193'><span id='am-12' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-13' property="rdfs:label" content="Beta" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasRelatedSynonym" content="Beta L. 1753" datatype="xsd:string"></span><span id='am-16'  ></span>beta</span>-glycerophosphate, 2 mM DTT, 0.1 mM Na3VO4, 10 mM <br />                                            MgCl2, Cell Signaling) supplemented 5 &#181;Ci &#947;33P-ATP (3000 Ci/mmol; PerkinElmer <br />                                            Life Sciences). The reaction mix incubated 1 h 30&#176;C. The reaction stopped by <br />                                            addition 10 &#181;L 5 &#215; Laemmli buffer samples incubated 5 min 95&#176;C prior to <br />                                            SDS gel-electrophoresis subsequent immunoblotting, needed. <br />  <br />                               Immunocytochemistry <br />                                            HEK-293FT cells plated glass coverslips transfected Lipofectamine 2000 at <br />                                            50% confluency. After 48 hours, transfected cells fixed 4% paraformaldehyde <br />                                            1&#215; PBS 10 minutes room temperature. The cells washed 3 times PBS 5 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            minutes incubated 0.3% triton X-100 PBS 1% bovine serum <br />                                            albumin (BSA) 1 hour room temperature. The cells incubated 1:1000 <br />                                            dilution anti-V5 anti-FLAG antibodies overnight room temperature. After washing <br />                                            cells 3 times PBS 5 minutes each, cells incubated 1:750 dilution <br />                                            FITC-conjugated goat anti-rabbit antibody (Jackson ImmunoResearch) 1&#215; PBS. The <br />                                            washes repeated 1&#215; PBS cells incubated 1:750 dilution Texas <br />                                            Red conjugated donkey anti-mouse antibody (Jackson ImmunoResearch). After washing the <br />                                            cells 3 times 1&#215; PBS 5 minutes each, embedded Antifade DAPI gel <br />                                            mounting medium (Invitrogen). Antibody N-terminus APP (22C11, Calbiochem) <br />                                            used marker cell membranes. <br />  <br />                               Microscopy <br />                                            The cells visualized three-dimensional multiple wavelength fluorescence <br />                                            microscopy using Olympus IX70 microscope equipped SoftWor&#215; 3.3.6, Deltavision <br />                                            90000 (Applied Precision) DAPI, FITC Texas Red fluorescence room temperature <br />                                            using oil immersion 60&#215; Olympus PlanApo objective (aperture set 1.40). The images <br />                                            captured using HP CoolSNAP <span id='am-50' about='obo:NCBITaxon_274080' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33154 obo:NCBITaxon_65171 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_7408 obo:NCBITaxon_7401 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_231877 obo:NCBITaxon_172377 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7400 obo:NCBITaxon_33392 obo:NCBITaxon_7399 obo:NCBITaxon_50557'><span id='am-51' property="rdfs:label" content="Camera" datatype="xsd:string"></span><span id='am-52' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-54'  ></span>camera</span>, deconvolved using SoftWor&#215; software <br />                                            (Applied Precision), examined single sections projections entire stack <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            optical sections. All images processed using Adobe Photoshop CS2. <br />  <br />                                            C. elegans&#8212;Transgenic LRRK2 C. elegans lines generated described Saha et <br />                                            al (Saha et al. 2009). The WT LRRK2 wlzIs2 line crossed sek-1 [km4] line and <br />                                            bred homozygocity (Tanaka-Hino et al. 2002). The presence LRRK2 km4 <br />                                            deletion validated PCR. RNAi knockdown performed according Kamath et <br />                                            al. (Kamath et al. 2001). Non-transgenic Bristol N2 WT LRRK2 worms allowed to <br />                                            lay eggs 3 hours NGM plates containing OP50 bacteria. After 3 days, synchronized <br />                                            young adult <span id='am-55' about='obo:NCBITaxon_333870' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_41084 obo:NCBITaxon_33154 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_195229 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_41087 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_71193 obo:NCBITaxon_33392 obo:NCBITaxon_50557 obo:NCBITaxon_7041'><span id='am-56' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-57'  ></span><span id='am-58' property="oboInOwl:hasRelatedSynonym" content="Nematodes Berthold, 1827" datatype="xsd:string"></span><span id='am-59' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-60' property="rdfs:label" content="Nematodes" datatype="xsd:string"></span>nematodes</span> moved NGM plates feed HT115 bacteria containing <br />                                            vector PL4440 double-stranded RNAi expressing plasmid 2 additional <br />                                            days. 25 adult worms moved triplicate plates containing 25 &#181;M rotenone and <br />                                            HT115 bacteria. NGM plates 1 mM IPTG constant induction of <br />                                            RNAs. Nose-poke assays performed identify quantify live worms 4 days. <br />  <br />  <br />  <br />                                                 J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                            Page 5 <br />  <br />  <br />                               Statistical analysis <br />                                            All data expressed mean &#177; SEM graphed using Excel Prism (GraphPad). <br />                                            One-way ANOVA Tukey&#8217;s post hoc tests performed identify statistically <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            significant differences using InStat (GraphPad). <br />  <br />                               RESULTS <br />                               LRRK2 binds MKK3 6 <br />                                            HEK-293FT cells transiently transfected V5-His tagged WT LRRK2 Flag- <br />                                            tagged MKK3 MKK6. Protein complexes containing MKK6 (Fig. 1 A) MKK3 (SI Fig. <br />                                            S2 A) evident co-immunoprecipitation LRRK2 MKKs. Interestingly, <br />                                            co-transfecting LRRK2 MKK6 increased total levels MKK6, shown the <br />                                            input lanes Fig. 1A &amp; C. Analysis LRRK2 deletion mutants demonstrated LRRK2 <br />                                            COR kinase domains essential sufficient binding MKK6 (Fig. 1 B) and <br />                                            MKK3 (Fig. S2 B). In contrast, LRR domain required binding. Selectivity <br />                                            apparent study MKK mutants, dominant negative MKK <br />                                            mutation K82A strongly reduced binding LRRK2 MKK6 (Fig. 1 C) MKK3 <br />                                            (Fig. S2 D). Finally, examined LRRK2 associated endogenous MKK6. <br />                                            HEK-293 FT cells transfected vector V5-tagged wild-type LRRK2. <br />                                            Lysates collected co-immunoprecipitation buffer, passed anti-V5 column <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            eluted V5-peptide. Endogenous MKK6 readily apparent eluate V5- <br />                                            LRRK2 transfected lysates absent vector-transfected lysates (Fig.1D). <br />                                            Immuboblots cell lysates immunoprecipitation showed increase in <br />                                            endogenous MKK6 levels transfection LRRK2 (Fig. 1D), similar to <br />                                            increase observed Figures 1A &amp; C. These results suggest LRRK2 interacts with <br />                                            MKK6 MKK3. <br />  <br />                               LRRK2 binds MKK7 MKK4 <br />                                            Because JNK pathway regulated MKK4 MKK7, hypothesize LRRK2 <br />                                            interact MKKs. Co-immunoprecipitation experiments demonstrated <br />                                            LRRK2 binds MKK7 MKK4 (Fig. 2 A). The LRRK2 kinase COR <br />                                            domains essential sufficient interaction MKK7 (Fig. 2 B), similar that <br />                                            observed MKK6 MKK3. The dominant negative K82A mutation completely <br />                                            abolished binding MKK7 LRRK2 (Fig. 2 C), suggesting similar the <br />                                            interaction MKK6 LRRK2, LRRK2/MKK7 interaction dependent the <br />                                            activation MKK7. We observed co-transfecting LRRK2 MKK4 7 was <br />                                            associated increase MKK levels similar seen MKK6 (Fig. 2A &amp; C). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               LRRK2 weakly phosphorylates MKKs <br />                                            The association LRRK2 MKKs led hypothesize families of <br />                                            kinases potentially mutual substrates. Recent studies indicate LRRK2 <br />                                            phosphorylates recombinant MKKs (Gloeckner et al. 2009). To test hypothesis, <br />                                            radioactive kinase assays performed using Flag-tagged MKK3, 6 7 <br />                                            immunoprecipitated HEK-293FT cells recombinant LRRK2 (fig. 3A &amp; B). <br />                                            Phosphorylation measured using 32P-ATP (fig. 3A, C &amp; D). Incubating WT G2019S <br />                                            LRRK2 MKK3, 6 7 moderately stimulated phosphorylation MKK3 MKK7, <br />                                            marginal effects MKK6 (fig. 3C). Phosphorylation required LRRK2 kinase <br />                                            activity kinase dead LRRK2 able stimulate MKK phosphorylation (fig. <br />                                            3A &amp; C). Interestingly, MKKs appeared reduce autophosphorylation of <br />                                            G2019S LRRK2 (fig. 3D). These data provide evidence LRRK2 modify MKK <br />                                            function, vice-versa. The phosphorylation modest, changes in <br />  <br />  <br />                                                 J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                             Page 6 <br />  <br />  <br />                                           phosphorylation downstream kinases, JNK p38, observed over- <br />                                           expressing WT G2019S LRRK2 (data shown), consistent prior reports <br />                                           (Liou et al. 2008). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Co-expressing LRRK2 MKK6 increases levels MKK6 membrane in <br />                               cytoplasm <br />                                           The activity MAPK cascades regulated factors phosphorylation. <br />                                           The regulation MAPK specificity frequently requires tethering appropriate kinases <br />                                           scaffold proteins form stimuli-specific module, module targeted <br />                                           appropriate subcellular compartment activation downstream signals (Garrington <br />                                           &amp; Johnson 1999). We hypothesized LRRK2 act scaffold protein to <br />                                           recruit MKKs specific subcellular compartments. To test hypothesis, investigated <br />                                           co-expression LRRK2 altered distribution MKK6. HEK-293FT cells were <br />                                           transfected WT LRRK2 WT dominant negative MKK6, lysates <br />                                           fractionated cytosolic membrane fractions (Fig. 4A). Expressing WT LRRK2 <br />                                           increased levels MKK6 membrane fraction approximately 4-fold (Fig. 4 A &amp; B). <br />                                           Total MKK6 levels increased co-expression LRRK2, increase <br />                                           (~50%) change seen membrane fraction (Fig. 4A). LRRK2 <br />                                           expression appeared somewhat reduced co-expressed dominant negative <br />                                           MKK6 compared WT MKK6, occurred cytoplasm membrane <br />                                           fractions (fig. 4A). To examine subcellular localization MKKs, focused the <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           interaction MKK6 using imaging, performed immunocytochemistry utilizing an <br />                                           antibody N-terminus amyloid precursor protein (22C11) <span id='am-75' about='rdfs:label' typeof='owl:Thing'>label</span> membrane. <br />                                           Co-localization MKK6 membrane marker (amyloid precursor protein) increased <br />                                           cells co-transfected LRRK2 MKK6, compared cells expressing MKK6 alone <br />                                           (fig. 4C); pattern reactivity suggested localization plasma membrane. <br />  <br />                                           We examined co-expression MKK6 changed subcellular localization <br />                                           LRRK2. The fractionation studies showed increases cytoplasmic membrane <br />                                           levels LRRK2 (fig. 4A). We proceeded examine question by <br />                                           Immunocytochemistry. Cells co-expressed LRRK2 MKK6 showed pattern of <br />                                           reactivity distinct &#8220;rim&#65533;? reactivity, compared cells expressing LRRK2 <br />                                           cells expressing dnMKK6 (fig. 5). These data consistent increased membrane <br />                                           binding, MKK6 increases total levels LRRK2, microscopy alone <br />                                           rule-out changes result simply increased expression. <br />  <br />                               MKK6 p38 orthologs C. elegans required LRRK2 function <br />                                           To gain insight role MKK6 LRRK2 function vivo examine whether <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           endogenous MKKs regulated LRRK2 function neurons, utilized transgenic C. elegans <br />                                           lines express human WT LRRK2 driven synaptobrevin promoter, a <br />                                           neuron-specific promoter. We recently generated lines C. elegans expressing LRRK2 and <br />                                           showed LRRK2 complements function C. elegans ortholog, lrk-1 a <br />                                           rotenone-protection assay (Saha et al. 2009). Nematode lines expressing WT LRRK2 were <br />                                           strongly protected toxicity rotenone, mitochondrial complex I inhibitor (Saha et <br />                                           al. 2009). The strong phenotype associated LRRK2 expression provides robust assay <br />                                           test genetic pathways mediating LRRK2 function. <br />  <br />                                           RNAi used knock C. elegans MKK6/3 ortholog sek-1 downstream <br />                                           target, p38 MAPK ortholog pmk-1. Non-transgenic Bristol N2 WT LRRK2 C. elegans <br />                                           exposed RNAi feeding <span id='am-61' about='obo:NCBITaxon_29278' typeof='owl:Thing obo:NCBITaxon_81077 obo:NCBITaxon_1 obo:NCBITaxon_28384'><span id='am-62' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-63' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-64' property="rdfs:label" content="vectors" datatype="xsd:string"></span>vectors</span> coding sek-1 pmk-1 exposed 25 <br />                                           &#181;M rotenone 4 days maintaining RNAi treatment. We observed nematodes <br />                                           expressing LRRK2 protected rotenone (Fig. 6), consistent our <br />  <br />  <br />                                                J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                            Page 7 <br />  <br />  <br />                                          prior results (Saha et al. 2009). Knockdown sek-1 (Fig. 6A) pmk-1 (Fig. 6B) <br />                                          completely abolished ability WT LRRK2 protect C. elegans rotenone, <br />                                          control vector effect. Analysis mRNA levels real time PCR <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          indicated 60 &#177; 9% (P &lt; 0.01, N=3) decrease expression sek-1 transcript a <br />                                          similar decrease pmk-1. The role MKK3/6 (sek-1) confirmed deleting the <br />                                          sek-1 gene WT LRRK2 wlzIs2 crossing sek-1 [km4] C. elegans line, <br />                                          carries deletion sek-1 exons 4&#8211;6 (www.wormbase.org), breeding to <br />                                          homozygocity (Tanaka-Hino et al. 2002). The effects rotenone toxicity then <br />                                          examined. The LRRK2 wlzIs2 line showed strong resistance rotenone toxicity, the <br />                                          LRRK2/sek-1 [km4] line showed protection (Fig. 6C). Finally, examined whether <br />                                          endogenous lrk-1 required protection sek1 pmk-1. To determine sek-1 <br />                                          pmk-1 required lrk-1 modify rotenone toxicity, examined effects sek-1 and <br />                                          pmk-1 knockdown lrk-1 [km17] C. elegans line deletion lrk-1. The lrk-1 <br />                                          [km17] line highly sensitive rotenone (25 &#181;M, 4 days), expected. In addition, <br />                                          pmk-1 knockdown provided protection effect sek-1 knockdown less <br />                                          observed N2 line contains active lrk-1 (fig. 6D lrk-1[km17] line, vs. <br />                                          fig. 6A&amp;B lines containing lrk-1). Taken data suggest lrk-1 and <br />                                          LRRK2 require sek-1 pmk-1 action (the C. elegans homologues MKK6 p38), <br />                                          vice versa. <br />  <br />                               Disease-linked mutations LRRK2 modify binding <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Finally, tested mutations LRRK2 associated disease modified <br />                                          interaction LRRK2 MKKs. HEK 293 cells transfected LRRK2 <br />                                          (WT, G2019S, R1441C, Y1699C I2020T) MKK6. LRRK2 then <br />                                          immunoprecipitated binding MKK6 quantified immunoblot (Fig. 7A &amp; B). The <br />                                          G2019S, R1441C I2020T mutations enhanced binding LRRK2 MKK6, but <br />                                          Y1699C mutation did alter binding (Fig. 7 A &amp; B). The enhanced binding the <br />                                          mutant LRRK2 exerted stronger effects MKK6 MKK3 7 binding; R1441C <br />                                          G2019S mutations did statistically significant increases binding LRRK2 <br />                                          MKK7 (Fig. 7 C &amp; D) MKK3 (Fig. S2 C). <br />  <br />                               DISCUSSION <br />                                          Our results indicate LRRK2 interacts MKK3, 6 7. We provide multiple <br />                                          independent lines investigation supporting hypothesis LRRK2 interacts the <br />                                          MKKs. LRRK2 binds MKK3, 6, 7, R1441C LRRK2 mutation increases <br />                                          binding MKK6. LRRK2 phosphorylates MKK3 MKK7 vitro relatively <br />                                          minor effect MKK6 phosphorylation. Co-expression LRRK2 MKK6 increased <br />                                          levels protein observed expression protein alone. Co- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          expression increased levels LRRK2 MKK6 membrane the <br />                                          cytoplasm. Membrane localization LRRK2 MKK6 evident using biochemical <br />                                          fractionation, immunocytochemical studies. Finally, cellular studies are <br />                                          complemented studies showing knockdown deletion MKK6 (sek-1) p38 <br />                                          (pmk-1) C. elegans abrogates LRRK2-mediated protection rotenone toxicity, <br />                                          demonstrates endogenous MKK6 required LRRK2 function. Together, <br />                                          data point role MKKs JNK/p38 pathways LRRK2 function. Our <br />                                          data consistent hypothesis interaction MKKs LRRK2 affects <br />                                          different biochemical processes, protein translation (or degradation) membrane <br />                                          association. <br />  <br />                                          We observed robust binding LRRK2 MKK3, 6 7, MKK4. The structures <br />                                          MKK4 MKK2 differ N-termini, conserved, three <br />                                          short sequences (MKK4 amino acids 193-9, 278&#8211;283 329-35) conserved for <br />  <br />                                               J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                          Page 8 <br />  <br />  <br />                                         MKK 3, 6 7 MKK4. Future studies determine these <br />                                         domains contribute specificity LRRK2 binding. The domains LRRK2 regulate <br />                                         binding identified deletion studies showed similar binding patterns MKK3, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         6 7. Each MKKs bound LRRK2 deletion constructs containing COR and <br />                                         kinase domains, LRR domain LRRK2. Other studies highlight the <br />                                         importance ROC COR domains. The ROC domain LRRK2 contributes its <br />                                         <span id='am-45' about='obo:NCBITaxon_9605' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_9526 obo:NCBITaxon_9604 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_32524 obo:NCBITaxon_117570 obo:NCBITaxon_32525 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_1437010 obo:NCBITaxon_1338369 obo:NCBITaxon_40674 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_314146 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_314293 obo:NCBITaxon_314295 obo:NCBITaxon_376913 obo:NCBITaxon_7776 obo:NCBITaxon_9347 obo:NCBITaxon_207598 obo:NCBITaxon_9443'><span id='am-46'  ></span><span id='am-47' property="rdfs:label" content="Homo" datatype="xsd:string"></span><span id='am-48' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-49' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>homo</span>-dimerization (Greggio et al. 2008), sequences outside ROC-COR bi- <br />                                         domain required dimer formation (Klein et al. 2009, Greggio et al. 2008). <br />                                         LRRK2 binds CHIP, ubiquitin ligase binds Hsp-70, interaction occurs the <br />                                         COR ROC domains (Ko et al. 2009). The ROC COR domains (as kinase <br />                                         domain) necessary phosphorylation moesin (Jaleel et al. 2007). Several other <br />                                         putative LRRK2 binding proteins identified, including Fas binding <br />                                         protein, Hsp90, 4E-BP JIP1-4, studies analyzed domain <br />                                         requirements binding (Ho et al. 2009, Dachsel et al. 2007, Imai et al. 2008, Hsu et al. <br />                                         2009). Thus, ROC COR domains appear play particularly important roles the <br />                                         association LRRK2 proteins. <br />  <br />                                         Our study identifies new group proteins regulate levels LRRK2 the <br />                                         membrane association LRRK2. Co-expressing LRRK2 MKKs increased total <br />                                         levels LRRK2 MKKs (fig. 1, 2 &amp; 4). We hypothesize changes regulated <br />                                         level translation degradation expression increased the <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         transgenic proteins (LRRK2 MKKs), regulated constitutive CMV <br />                                         promoter, endogenous MKK6 (fig. 1). Prior studies indicate LRRK2 binds the <br />                                         protein 4E-BP, inhibits protein translation, stimulating 4E-BP with <br />                                         rapamycin suppress phenotypes associated PD (Imai et al. 2008,Tain et al. 2009). <br />                                         We recently confirmed LRRK2 phosphorylates 4E-BP, phosphorylation <br />                                         observed vitro, cell systems (Kumar et al. 2009). Interestingly, we <br />                                         p38, potential effector MKK activity convincing kinase than <br />                                         LRRK2 4EBP. Whether direct mediated intermediate kinases, interaction <br />                                         LRRK2 4E-BP provides link LRRK2 protein translation could <br />                                         contribute changes LRRK2 levels associated co-expressing MKKs. Further <br />                                         studies needed clarify LRRK2 complex includes MKKs 4E- <br />                                         BP proteins linked protein translation. <br />  <br />                                         LRRK2 localizes membranes significance localization poorly <br />                                         understood (West et al. 2005, Biskup et al. 2006, Higashi et al. 2007). Our studies suggest <br />                                         co-transfecting LRRK2 MKK6 (and possibly MKKs) increases membrane <br />                                         association MKK6. Whether increase LRRK2 membrane localization <br />                                         remains ambiguous increase total LRRK2 associated MKK co- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         transfection account apparent increase LRRK2 membrane localization. <br />                                         Although hypothesis association LRRK2 membranes regulate <br />                                         localization proteins new, multiple prior studies provide clear evidence for <br />                                         localization LRRK2 membranes. Studies Hatana et al. (Hatano et al. 2007) <br />                                         indicate LRRK2 localizes plasma membrane lipid rafts, studies by <br />                                         groups demonstrate LRRK2 associates organelle membranes (West et al. <br />                                         2005, Biskup et al. 2006, Higashi et al. 2007). The observation LRRK2 regulates MKK <br />                                         localization complements recent studies laboratory indicating LRRK2 <br />                                         binds JIP1 &#8211; 4, scaffold proteins bring MKKs MAPKs (e.g., <br />                                         JNK p38) (Hsu et al. 2009). JIPs appear function directing MAP kinase <br />                                         signaling complex different sites cells (Whitmarsh 2006). We hypothesize that <br />                                         LRRK2 acts complex facilitate localization MKK/MAPK proteins to <br />                                         sites stress. <br />  <br />  <br />  <br />                                              J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                          Page 9 <br />  <br />  <br />                                         The actions LRRK2 appear differ RIPs MLKs, despite moderate <br />                                         homology proteins. The RIPs MLKs thought function multi-tiered <br />                                         phosphorylating appropriate downstream MAPKK, turn <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         phosphorylates activates JNK p38 regulate specific transcription factors and <br />                                         cellular responses. This contrasts relatively modest phosphorylation the <br />                                         MKKs LRRK2. We able repeat observations Gloeckner et al showing that <br />                                         LRRK2 phosphorylates MKKs 3, 6 7. However, concentration MKKs needed to <br />                                         elicit phosphorylation MKKs quite high (40-fold greater LRRK2), which <br />                                         suggests small fraction MKK actually phosphorylated LRRK2, <br />                                         reminiscent recent observations low level 4EBP phosphorylation LRRK2. The <br />                                         low level phosphorylation explain changes MKK, JNK p38 <br />                                         phosphorylation evident co-transfection proteins. <br />  <br />                                         The modest effects kinase domain consistent results observed C. elegans <br />                                         Drosophila (Saha et al. 2009, Wang et al. 2008). In C. elegans, kinase <br />                                         dead LRRK2 functional protected toxicity induced rotenone, <br />                                         WT LRRK2 (Saha et al. 2009). Similar results observed in <br />                                         Drosophila, Wang colleagues observed deletion kinase domain from <br />                                         Drosophila LRRK2 homolog protected toxicity induced rotenone paraquat <br />                                         (Wang et al. 2008). These studies suggest LRRK2 exhibits multiple physiological <br />                                         actions, independent kinase activity. This type kinase-independent <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         regulation similar observed RIP kinases, closest homologues of <br />                                         LRRK2 (Festjens et al. 2007). RIP-1 activates NF-kB response DNA damage a <br />                                         mechanism does require RIP-1 kinase activity (Festjens et al. 2007). However, other <br />                                         pathways regulated RIP-1, TNF-receptor/MEK-1/ERK cascade, require <br />                                         RIP-1 kinase activity (Festjens et al. 2007). <br />  <br />                                         Studies LRRK2 beginning illuminate functional role LRRK2. Experiments in <br />                                         mammalian cells indicate LRRK2 potentiates peroxide-induced neurotoxicity a <br />                                         kinase dependent manner (West et al. 2007). The studies vivo support role LRRK2 <br />                                         response stress, differ details (Saha et al. 2009, Wang et al. 2008). We <br />                                         observed WT LRRK2 protects toxicity induced rotenone paraquat C. <br />                                         elegans, inhibit complex I <span id='am-65' about='obo:NCBITaxon_1118549' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_8936 obo:NCBITaxon_1329799 obo:NCBITaxon_1 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_32524 obo:NCBITaxon_436489 obo:NCBITaxon_117570 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_57387 obo:NCBITaxon_33154 obo:NCBITaxon_8782 obo:NCBITaxon_436486 obo:NCBITaxon_1338369 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_8492 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_8825 obo:NCBITaxon_7776 obo:NCBITaxon_436492 obo:NCBITaxon_32561 obo:NCBITaxon_8457 obo:NCBITaxon_436491'><span id='am-66' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-67' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-68'  ></span><span id='am-69' property="rdfs:label" content="Electron" datatype="xsd:string"></span>electron</span> transport chain (Saha et al. 2009). <br />                                         The G2019S R1441C LRRK2 mutants reduced protection mitochondrial <br />                                         inhibition actually increase degeneration dopaminergic neurons basal <br />                                         conditions mitochondrial inhibition (Saha et al. 2009). LRRK2 expression C. <br />                                         elegans complements function lrk-1, homolog LRRK2 C. elegans, and <br />                                         knockdown deletion lrk-1 potentiates rotenone toxicity (Saha et al. 2009, Sakaguchi- <br />                                         Nakashima et al. 2007). Wang colleagues observed similar results, study <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         pointed selective role LRRK2 protecting toxicity induced hydrogen <br />                                         peroxide (Wang et al. 2008). The selective toxicity observe mutant LRRK2 is <br />                                         consistent studies transgenic mice, rats neuronal SY5Y cells suggest <br />                                         mutant forms LRRK2 toxic WT LRRK2 (Li et al. 2009, Greggio <br />                                         et al. 2006, Greggio et al. 2007, Macleod et al. 2006, Smith et al. 2005). In current <br />                                         manuscript, extend observations demonstrating LRRK2-mediated stress <br />                                         response requires activity MKK6/sek-1 p38/pmk-1 pathway, blocking <br />                                         pathway abrogated protection LRRK2 C. elegans. Knockdown MKK6/sek-1 or <br />                                         p38/pmk-1 protects rotenone-mediated toxicity non-transgenic nematodes, and <br />                                         brings protection level equal seen LRRK2 expression. Conversely, <br />                                         knockdown MKK6/sek-1 p38/pmk-1 LRRK2 nematodes effectively abrogates the <br />                                         protection LRRK2 brings protection level non-transgenic nematodes. <br />                                         These data consistent hypothesis LRRK2 acts mechanism involving <br />                                         MKK6/sek-1 p38/pmk-1. <br />  <br />  <br />                                              J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                                              Page 10 <br />  <br />  <br />                                           Whether MAPK cascade contributes disease remains unclear. In current study, the <br />                                           G2019S, R1441C I2020T LRRK2 mutant constructs showed increased binding to <br />                                           MKKs, Y1699C LRRK2 mutation did statistically significant <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           increase binding. Binding MKK3 7 did statistically significant changes, <br />                                           apparent mutation-linked differences raises possibility future studies <br />                                           using larger sample sizes identify significant effects. These results parallel other <br />                                           binding studies, identify specific binding interaction altered large <br />                                           panel disease-linked mutations (Imai et al. 2008, Ko et al. 2009, Ho et al. 2009, Dachsel <br />                                           et al. 2007, Jaleel et al. 2007); (Hsu et al. 2009). Studies phosphorylation inclusion <br />                                           formation effects consistent disease-linked mutations <br />                                           (Greggio et al. 2006, Greggio et al. 2007, Smith et al. 2005, Gloeckner et al. 2009, Greggio <br />                                           et al. 2008, Ito et al. 2007, West et al. 2005). The notable exception trend binding <br />                                           LRRK2 Fas-associated protein, does robust increases binding a <br />                                           panel different LRRK2 mutations (Ho et al. 2009). The Fas-associated protein <br />                                           utilizes signal transduction pathway mediated RIP kinases mediated MKKs <br />                                           (Festjens et al. 2007). Thus, Fas-mediated pathway involving MKKs contribute to <br />                                           pathophysiology PD, information needed conclusion <br />                                           stated strong confidence. <br />  <br />                                           The increasing evidence linking LRRK2 function stress response, particular to <br />                                           MAPK pathways, illuminates biological function ultimately reveal <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           biological mechanisms linked PD. Many studies shown p38 JNK actions are <br />                                           crucial regulation cell death PD models. CHOP/Gadd153, transcription factor <br />                                           downstream p38, up-regulated 6-OHDA 1-methyl-4-phenylpyridinium <br />                                           (MPP+) treatments dopaminergic cell line. Manganese 6-OHDA treatments also <br />                                           strongly activate p38 JNK pathways increasing phosphorylated p38 c-jun (Holtz <br />                                           &amp; O&apos;Malley 2003). c-Jun activated dopaminergic neurons PD patients 1- <br />                                           methyl-4-phenyl-1,2,4,6 tetrahydropyridine (MPTP) mouse model PD. JNK2 JNK3, <br />                                           JNK 1, required MPTP-induced c-jun activation elimination <br />                                           JNK2 JNK3 prevent neurodegeneration improve motor function MPTP-treated <br />                                           mice (Hunot et al. 2004). Inhibitors JNK MLK CEP1347 shown to <br />                                           protective various vitro vivo PD models (Roux et al. 2002, Silva et al. 2005). <br />                                           Our data suggest role LRRK2 p38 JNK cascades response stresses <br />                                           related PD. <br />  <br />                               Supplementary Material <br />                                           Refer Web version PubMed Central supplementary material. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Acknowledgments <br />                                           We thank Roger Davis generosity sharing MKK <span id='am-91' about='obo:NCBITaxon_36549' typeof='owl:Thing obo:NCBITaxon_1 obo:NCBITaxon_28384'><span id='am-92' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-93' property="oboInOwl:hasDbXref" content="GC_ID:11" datatype="xsd:string"></span><span id='am-94' property="oboInOwl:hasAlternativeId" content="NCBITaxon:2435" datatype="xsd:string"></span><span id='am-95' property="rdfs:label" content="plasmids" datatype="xsd:string"></span>plasmids</span>, Leonard Petrucelli valuable <br />                                           advice. We thank Shelley Russek Ramona Faris assistance luciferase assays, Andrew <br />                                           Ferree help editing manuscript. This work supported NIEHS ES15567, NINDS NS41786, the <br />                                           Alzheimer Association Michael J. Fox Foundation (B.W.). This research supported the <br />                                           Intramural Research Program NIH, National Institute Aging, Z01AG000948 (M.R.C.). <br />  <br />  <br />                               ABBREVIATIONS <br />                                         COR              carboxy-terminal Ras <br />                                         JIP              c-Jun interacting protein <br />                                         JNK              c-Jun kinase <br />  <br />  <br />  <br />                                                 J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                                   Page 11 <br />  <br />  <br />  <br />  <br />                                         LRRK2           leucine-rich repeat kinase 2 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         MAPK            mitogen-activating protein kinase, MAPK <br />                                         MKK             MAPK kinase <br />                                         MLK             mixed-lineage kinase <br />                                         PD              Parkinson&#8217;s disease <br />                                         RIP             Receptor Interacting Protein kinase <br />                                         ROC             Ras complex <br />  <br />                               REFERENCES <br />                                           Biskup S, Moore DJ, Celsi F, et al. Localization LRRK2 membranous vesicular structures in <br />                                             mammalian brain. Ann Neurol 2006;60:557&#8211;569. [PubMed: 17120249] <br />                                           Dachsel JC, Taylor JP, Mok SS, et al. Identification potential protein interactors Lrrk2. <br />                                             Parkinsonism Relat Disord 2007;13 <br />                                           Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P. RIP1, kinase crossroads cell&apos;s <br />                                             decision live die. Cell Death Differ 2007;14:400&#8211;410. [PubMed: 17301840] <br />                                           Gallo KA, Johnson GL. Mixed-lineage kinase control JNK p38 MAPK pathways. Nat Rev Mol <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Cell Biol 2002;3:663&#8211;672. [PubMed: 12209126] <br />                                           Garrington TP, Johnson GL. Organization regulation mitogen-activated protein kinase signaling <br />                                             pathways. Curr Opin Cell Biol 1999;11:211&#8211;218. [PubMed: 10209154] <br />                                           Gloeckner CJ, Schumacher A, Boldt K, Ueffing M. The Parkinson disease-associated protein kinase <br />                                             LRRK2 exhibits MAPKKK activity phosphorylates MKK3/6 MKK4/7, vitro. J <br />                                             Neurochem 2009;109:959&#8211;968. [PubMed: 19302196] <br />                                           Greggio E, Cookson MR. Leucine-rich repeat kinase 2 mutations Parkinson&apos;s disease: three <br />                                             questions. ASN Neuro 2009;1 <br />                                           Greggio E, Jain S, Kingsbury A, et al. Kinase activity required toxic effects mutant <br />                                             LRRK2/dardarin. Neurobiol Dis 2006;23:329&#8211;341. [PubMed: 16750377] <br />                                           Greggio E, Lewis PA, van der Brug MP, Ahmad R, Kaganovich A, Ding J, Beilina A, Baker AK, <br />                                             Cookson MR. Mutations LRRK2/dardarin associated Parkinson disease toxic than <br />                                             equivalent mutations homologous kinase LRRK1. J Neurochem 2007;102:93&#8211;102. [PubMed: <br />                                             17394548] <br />                                           Greggio E, Zambrano I, Kaganovich A, et al. The Parkinson disease-associated leucine-rich repeat <br />                                               kinase 2 (LRRK2) dimer undergoes intramolecular autophosphorylation. J Biol Chem <br />                                               2008;283:16906&#8211;16914. [PubMed: 18397888] <br />                                           Hatano T, Kubo S, Imai S, Maeda M, Ishikawa K, Mizuno Y, Hattori N. Leucine-rich repeat kinase 2 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               associates lipid rafts. Hum Mol Genet 2007;16:678&#8211;690. [PubMed: 17341485] <br />                                           Higashi S, Moore DJ, Colebrooke RE, Biskup S, Dawson VL, Arai H, Dawson TM, Emson PC. <br />                                               Expression localization Parkinson&apos;s disease-associated leucine-rich repeat kinase 2 the <br />                                               mouse brain. J Neurochem 2007;100:368&#8211;381. [PubMed: 17101029] <br />                                           Ho CC, Rideout HJ, Ribe E, Troy CM, Dauer WT. The Parkinson disease protein leucine-rich repeat <br />                                               kinase 2 transduces death signals Fas-associated protein death domain caspase-8 a <br />                                               cellular model neurodegeneration. J Neurosci 2009;29:1011&#8211;1016. [PubMed: 19176810] <br />                                           Holtz WA, O&apos;Malley KL. Parkinsonian mimetics induce aspects unfolded protein response death <br />                                               dopaminergic neurons. J Biol Chem 2003;278:19367&#8211;19377. [PubMed: 12598533] <br />                                           Hsu C, Chan D, Wolozin B. LRRK2 Stress Response: Interaction MKKs JIPs. <br />                                               Neurodegener Dis. 2009 (in press). <br />                                           Hunot S, <span id='am-96' about='obo:NCBITaxon_127372' typeof='owl:Thing obo:NCBITaxon_37567 obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_127268 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_33415 obo:NCBITaxon_33317 obo:NCBITaxon_41191 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_37572 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_41196 obo:NCBITaxon_197563 obo:NCBITaxon_41197 obo:NCBITaxon_215752 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-97' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-98' property="rdfs:label" content="Vila" datatype="xsd:string"></span><span id='am-99'  ></span><span id='am-100' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>Vila</span> M, Teismann P, Davis RJ, Hirsch EC, Przedborski S, Rakic P, Flavell RA. JNK- <br />                                               mediated induction cyclooxygenase 2 required neurodegeneration mouse model of <br />                                               Parkinson&apos;s disease. Proc Natl Acad Sci U S A 2004;101:665&#8211;670. [PubMed: 14704277] <br />  <br />  <br />  <br />                                                 J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                                 Page 12 <br />  <br />  <br />                                         Iaccarino C, Crosio C, Vitale C, Sanna G, Carri MT, Barone P. Apoptotic mechanisms mutant <br />                                             LRRK2-mediated cell death. Hum Mol Genet 2007;16:1319&#8211;1326. [PubMed: 17409193] <br />                                         Imai Y, Gehrke S, Wang HQ, Takahashi R, Hasegawa K, Oota E, Lu B. Phosphorylation 4E-BP by <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             LRRK2 affects maintenance dopaminergic neurons Drosophila. Embo J 2008;27:2432&#8211; <br />                                             2443. [PubMed: 18701920] <br />                                         Ito G, Okai T, Fujino G, Takeda K, Ichijo H, Katada T, Iwatsubo T. GTP Binding Is Essential the <br />                                             Protein Kinase Activity LRRK2, Causative Gene Product Familial Parkinson&apos;s Disease. <br />                                             Biochemistry 2007;46:1380&#8211;1388. [PubMed: 17260967] <br />                                         Jaleel M, Nichols RJ, Deak M, Campbell DG, Gillardon F, Knebel A, Alessi DR. LRRK2 <br />                                             phosphorylates moesin threonine-558: characterization Parkinson&apos;s disease mutants <br />                                             affect kinase activity. Biochem J 2007;405:307&#8211;317. [PubMed: 17447891] <br />                                         Kamath RS, Martinez-Campos M, Zipperlen P, Fraser AG, Ahringer J. Effectiveness specific RNA- <br />                                             mediated interference ingested double-stranded RNA <span id='am-20' about='obo:NCBITaxon_6239' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_119089 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_55879 obo:NCBITaxon_131567 obo:NCBITaxon_55885 obo:NCBITaxon_6237 obo:NCBITaxon_6236 obo:NCBITaxon_33154 obo:NCBITaxon_6231 obo:NCBITaxon_1206794 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6243 obo:NCBITaxon_6072'><span id='am-21' property="rdfs:label" content="Caenorhabditis elegans" datatype="xsd:string"></span><span id='am-22'  ></span><span id='am-23' property="oboInOwl:hasRelatedSynonym" content="Rhabditis elegans" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasExactSynonym" content="roundworm" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Caenorhabditis elegans</span>. Genome <br />                                             Biol 2001;2 RESEARCH0002. <br />                                         Klein CL, Rovelli G, Springer W, Schall C, Gasser T, Kahle PJ. Homo- heterodimerization of <br />                                             ROCO kinases: LRRK2 kinase inhibition LRRK2 ROCO fragment. J Neurochem <br />                                             2009;111:703&#8211;715. [PubMed: 19712061] <br />                                         Ko HS, Bailey R, Smith WW, et al. CHIP regulates leucine-rich repeat kinase-2 ubiquitination, <br />                                             degradation, toxicity. Proc Natl Acad Sci U S A 2009;106:2897&#8211;2902. [PubMed: 19196961] <br />                                         Kumar A, Greggio E, Beilina A, Kaganovich A, Chan D, Wolozin B, Cookson M. The Parkinson&#8217;s <br />                                             disease associated LRRK2 exhibits weaker vitro phosphorylation 4E-BP compared to <br />                                             autophosphorylation. PLoS One. 2009 (in press). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Lewis PA, Greggio E, Beilina A, Jain S, Baker A, Cookson MR. The R1441C mutation LRRK2 <br />                                             disrupts GTP hydrolysis. Biochem Biophys Res Commun 2007;357:668&#8211;671. [PubMed: <br />                                             17442267] <br />                                         Li X, Tan YC, Poulose S, Olanow CW, Huang XY, Yue Z. Leucine-rich repeat kinase 2 (LRRK2)/ <br />                                             PARK8 possesses GTPase activity altered familial Parkinson&apos;s disease R1441C/G <br />                                             mutants. J Neurochem 2007;103:238&#8211;247. [PubMed: 17623048] <br />                                         Li Y, Liu W, Oo TF, et al. Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal <br />                                             features Parkinson&apos;s disease. Nat Neurosci. 2009 <br />                                         Liou AK, Leak RK, Li L, Zigmond MJ. Wild-type LRRK2 mutant attenuates stress-induced <br />                                             cell death ERK pathway. Neurobiol Dis 2008;32:116&#8211;124. [PubMed: 18675914] <br />                                         Livak KJ, Schmittgen TD. Analysis relative gene expression data using real-time quantitative PCR <br />                                             2(&#8722;<span id='am-81' about='obo:NCBITaxon_998453' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_33154 obo:NCBITaxon_50638 obo:NCBITaxon_7438 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_7434 obo:NCBITaxon_6960 obo:NCBITaxon_6072 obo:NCBITaxon_33208 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7400 obo:NCBITaxon_33392 obo:NCBITaxon_7399 obo:NCBITaxon_34725 obo:NCBITaxon_50557'><span id='am-82' property="rdfs:label" content="Delta" datatype="xsd:string"></span><span id='am-83' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-84'  ></span><span id='am-85' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>Delta</span> Delta C(T)) Method. Methods 2001;25:402&#8211;408. [PubMed: 11846609] <br />                                         Macleod D, Dowman J, Hammond R, Leete T, Inoue K, Abeliovich A. The Familial Parkinsonism <br />                                             Gene LRRK2 Regulates Neurite Process Morphology. Neuron 2006;52:587&#8211;593. [PubMed: <br />                                             17114044] <br />                                         Olanow CW, Stern MB, Sethi K. The scientific clinical basis treatment Parkinson <br />                                             disease (2009). Neurology 2009;72:S1&#8211;S136. [PubMed: 19470958] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Plowey ED, Cherra SJ 3rd, Liu YJ, Chu CT. Role autophagy G2019S-LRRK2-associated neurite <br />                                             shortening differentiated SH-SY5Y cells. J Neurochem 2008;105:1048&#8211;1056. [PubMed: <br />                                             18182054] <br />                                         Roux PP, Dorval G, Boudreau M, Angers-Loustau A, Morris SJ, Makkerh J, Barker PA. K252a and <br />                                             CEP1347 neuroprotective compounds inhibit mixed-lineage kinase-3 induce <br />                                             activation Akt ERK. J Biol Chem 2002;277:49473&#8211;49480. [PubMed: 12388555] <br />                                         Saha S, Guillily M, Ferree A, et al. LRRK2 modulates vulnerability mitochondrial dysfunction C. <br />                                             elegans. J. Neuroscience. 2009 In press. <br />                                         Sakaguchi-Nakashima A, Meir JY, Jin Y, Matsumoto K, Hisamoto N. LRK-1, C. elegans PARK8- <br />                                             related kinase, regulates axonal-dendritic polarity SV proteins. Curr Biol 2007;17:592&#8211;598. <br />                                             [PubMed: 17346966] <br />                                         Silva RM, Kuan CY, Rakic P, Burke RE. Mixed lineage kinase-c-jun N-terminal kinase signaling <br />                                             pathway: new therapeutic target Parkinson&apos;s disease. Mov Disord 2005;20:653&#8211;664. [PubMed: <br />                                             15719422] <br />  <br />  <br />  <br />                                              J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                                 Page 13 <br />  <br />  <br />                                         Smith WW, Pei Z, Jiang H, Dawson VL, Dawson TM, Ross CA. Kinase activity mutant LRRK2 <br />                                             mediates neuronal toxicity. Nat Neurosci 2006;9:1231&#8211;1233. [PubMed: 16980962] <br />                                         Smith WW, Pei Z, Jiang H, Moore DJ, Liang Y, West AB, Dawson VL, Dawson TM, Ross CA. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Leucine-rich repeat kinase 2 (LRRK2) interacts parkin mutant LRRK2 induces neuronal <br />                                             degeneration. Proc Natl Acad Sci U S A 2005;102:18676&#8211;18681. [PubMed: 16352719] <br />                                         Tain LS, Mortiboys H, Tao RN, Ziviani E, Bandmann O, Whitworth AJ. Rapamycin activation 4E- <br />                                             BP prevents parkinsonian dopaminergic neuron loss. Nat Neurosci 2009;12:1129&#8211;1135. [PubMed: <br />                                             19684592] <br />                                         Tanaka-Hino M, Sagasti A, Hisamoto N, Kawasaki M, Nakano S, Ninomiya-Tsuji J, Bargmann CI, <br />                                             Matsumoto K. SEK-1 MAPKK mediates Ca2+ signaling determine neuronal asymmetric <br />                                             development <span id='am-27' about='obo:NCBITaxon_6237' typeof='owl:Thing obo:NCBITaxon_33208 obo:NCBITaxon_119089 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_55879 obo:NCBITaxon_131567 obo:NCBITaxon_55885 obo:NCBITaxon_6236 obo:NCBITaxon_33154 obo:NCBITaxon_6231 obo:NCBITaxon_1206794 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6243 obo:NCBITaxon_6072'><span id='am-28' property="rdfs:label" content="Caenorhabditis" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-31'  ></span>Caenorhabditis</span> elegans. EMBO Rep 2002;3:56&#8211;62. [PubMed: 11751572] <br />                                         Wang D, Tang B, Zhao G, <span id='am-32' about='obo:NCBITaxon_9596' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_9526 obo:NCBITaxon_9604 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_32524 obo:NCBITaxon_117570 obo:NCBITaxon_32525 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_1437010 obo:NCBITaxon_1338369 obo:NCBITaxon_40674 obo:NCBITaxon_8287 obo:NCBITaxon_2759 obo:NCBITaxon_314146 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_314293 obo:NCBITaxon_314295 obo:NCBITaxon_376913 obo:NCBITaxon_7776 obo:NCBITaxon_9347 obo:NCBITaxon_207598 obo:NCBITaxon_9443'><span id='am-33' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasAlternativeId" content="NCBITaxon:317028" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:hasExactSynonym" content="chimpanzees" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasAlternativeId" content="NCBITaxon:445518" datatype="xsd:string"></span><span id='am-37'  ></span><span id='am-38' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-39' property="rdfs:label" content="Pan" datatype="xsd:string"></span>Pan</span> Q, Xia K, Bodmer R, Zhang Z. Dispensable role Drosophila <br />                                             ortholog LRRK2 kinase activity survival dopaminergic neurons. Mol Neurodegener <br />                                             2008;3:3. [PubMed: 18257932] <br />                                         West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA, Dawson VL, Dawson TM. <br />                                             Parkinson&apos;s disease-associated mutations leucine-rich repeat kinase 2 augment kinase activity. <br />                                             Proc Natl Acad Sci U S A 2005;102:16842&#8211;16847. [PubMed: 16269541] <br />                                         West AB, Moore DJ, Choi C, et al. Parkinson&apos;s disease-associated mutations LRRK2 link enhanced <br />                                             GTP-binding kinase activities neuronal toxicity. Hum Mol Genet 2007;16:223&#8211;232. <br />                                             [PubMed: 17200152] <br />                                         Whitmarsh AJ. The JIP family MAPK scaffold proteins. Biochem Soc Trans 2006;34:828&#8211;832. <br />                                             [PubMed: 17052208] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Zimprich A, Biskup S, Leitner P, et al. Mutations LRRK2 Cause Autosomal-Dominant <br />                                             Parkinsonism Pleomorphic Pathology. Neuron 2004;44:601&#8211;607. [PubMed: 15541309] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                   Page 14 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Fig. 1. <br />                                         LRRK2 binds MKK6, pathogenic mutations LRRK2 increase binding of <br />                                         LRRK2 MKK6. LRRK2 activates p38 pathway. (A) LRRK2 co-immunoprecipitates <br />                                         MKK6 HEK-293FT cells. (B) LRRK2 kinase COR domains essential and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         sufficient interaction MKK6. (C) Dominant negative K82A mutation MKK6 <br />                                         reduces MKK6 binding LRRK2. All experiments performed times. D.) <br />                                         Eluate anti-V5 column shows association endogenous MKK6 LRRK2 <br />                                         (V5). Levels protein lysates shown below. <br />  <br />  <br />  <br />  <br />                                               J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                    Page 15 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Fig. 2. <br />                                         LRRK2 binds MKK7 MKK4 activates JNK pathway. (A) LRRK2 co- <br />                                         immunoprecipitates MKK7 MKK4 HEK-293FT cells. (B) LRRK2 kinase <br />                                         COR domains essential sufficient interaction MKK7. (C) Dominant <br />                                         negative K82A mutation MKK7 reduces MKK7 binding LRRK2. All experiments have <br />                                         performed times. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                   Page 16 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Fig. 3. <br />                                         LRRK2 stimulates MKK phosphorylation. A. Recombinant MKK3, 6 7 (Flag-tagged) <br />                                         incubated &#177; LRRK2 (WT, G2019S KD, GST-tagged), presence kinase <br />                                         buffer 32P-ATP. B. Coomassie gel showing purity recombinant MKK3, 6 and <br />                                         7. C &amp; D. Quantification MKK phosphorylation (C) LRRK2 autophosphorylation (D) <br />                                         densitometry. Error bars SEM independent experiments. <br />  <br />  <br />  <br />  <br />                                               J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                    Page 17 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Fig. 4. <br />                                         Expressing LRRK2 increases level MKK6 membrane fraction. (A) Both WT <br />                                         G2019S LRRK2 increased level membrane MKK6. (B) Quantification indicated <br />                                         level membrane MKK6 increased 4-fold expressed with <br />                                         LRRK2 (*p&lt;0.05; N=3, compared WT MKK6). There significant difference in <br />                                         level membrane MKK6 WT G2019S LRRK2-transfected samples. The <br />                                         level MKK6 membrane fraction normalized level MKK6 total <br />                                         lysate, compared samples transfected &#177; LRRK2. Experiments repeated <br />                                         times HEK-293FT cells. (C) Co-expression WT G2019S LRRK2 WT <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         MKK6 increased levels MKK6 present plasma membrane, shown co- <br />                                         localization amyloid precursor protein (APP). The arrows point LRRK2/APP co- <br />                                         localization. Bar, 15 &#181;m. All experiments performed times. <br />  <br />  <br />  <br />  <br />                                               J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                   Page 18 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                         Fig. 5. <br />                                         Co-expression LRRK2 MKK6 leads co-localization. HEK 293 cells co- <br />                                         transfected LRRK2 (WT G2019S) &#177; MKK6 (WT dominant negative). The <br />                                         proteins subsequently identified immunocytochemistry. WT G2019S LRRK2 <br />                                         co-localize WT MKK6. This co-localization reduced dominant negative MKK6, <br />                                         suggesting importance MKK6 function interaction LRRK2. The arrows <br />                                         point areas LRRK2 membrane localization. Bar, 15 &#181;m. All experiments been <br />                                         performed times. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               J Neurochem. Author manuscript; available PMC 2010 April 20. <br />                             Hsu et al.                                                                                          Page 19 <br /> NIH-PA <br /> </body></html>